Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by Lemoyneon Nov 08, 2024 12:06pm
127 Views
Post# 36303397

News releases

News releasesHow in the hell can you generate shareholder value with these news (posted over the past year and that were not related to earnings or meetings).
  • MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
  • MediPharm Labs Announces $2.1M Debt Repayment. Company Now Materially Debt Free with Over $13M in Cash
  • MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
  • MediPharm Labs Provides Update on German Cannabis Legalization
  • MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
1. Only 5 NRs !?!? Of which only one has a potential growth component (Remidose), and an insignificant one at that.

They freakin talked about shareholder value at their march cc and have done nothing to change it.

Financials show improvement, but heck, you gotta have visibility for people to notice those earnings. I wouldn't be surprised next earnings have no analyst showing up...

I mean, if they announce next earnings tonight, after markets close, before a long week end, what are they up to?

<< Previous
Bullboard Posts
Next >>